BBIO — BridgeBio Pharma, Inc. stock price, charts and financials

QT45BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
66.61
-0.70-1.04%
OverviewShort InterestFilings
BBIOQT45BridgeBio Pharma, Inc.·NASDAQ
66.61-1.04%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 31, 20268-KCurrent report
Aug 20, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 17, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 17, 20268-KCurrent report
Aug 14, 2026424B7424B7
Aug 10, 202610-QQuarterly report
Aug 10, 20268-KCurrent report
Aug 03, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 03, 20264Statement of changes in beneficial ownership
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 24, 2026S-3ASRS-3ASR
Jul 24, 2026S-8Registration of employee benefit securities
Jul 22, 20268-KCurrent report
Jul 13, 20264Statement of changes in beneficial ownership
Jul 13, 20264Statement of changes in beneficial ownership
Jul 10, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jul 02, 20268-KCurrent report
Jun 26, 20268-KCurrent report
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
#1 / 25 of 502
Page
▼
/ 21